|
I agree 100% with prognosis. I think the CORBA standard evolution has held VSGN back as an investment, since all these Wall Street folks you refer to know is Microsoft. There is a entrenched belief that anyone who competes with MSFT can't survive, and they refuse to accept that things are changing. Not that it's easy, but that is is possible and is happening. Objects is another cause for slower acceptance, but again gaining momentum. Thirdly, Visigenics is a developmental company with extensive losses caused by investing in growth. This during a period when Wall Street is focused on the nifty fifty and other Index fund stocks with high earnings. Again, momentum coming our way. VSGN financials have continued to improve nicely quarter over quarter, and trendline seems to be accelerating. We may be a "bit" early, but not much, IMO, and I'm glad I'm in at lower levels for the long term. Potential HOMERUN! |
